Bioventus (BVS) Net Margin Growth (1y) (2021 - 2026)
Bioventus (BVS) Net Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -860.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 469.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 92.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -777.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 350.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 85.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -81.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 67.00 |
| 10 | Bioventus | 972.23 Mn | 942.77 Mn | 105.67 Mn | 1,735.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 1,735.00 |
| Mar 28, 2026 | 567.00 |
| Apr 1, 2023 | -6,217.00 |
| Dec 31, 2022 | -1,857.00 |
| Oct 1, 2022 | -3,263.00 |
| Jul 2, 2022 | 962.00 |
| Apr 2, 2022 | -3,034.00 |
| Dec 31, 2021 | -230.00 |
| Oct 2, 2021 | -1,136.00 |
| Jul 3, 2021 | 49.00 |
| Apr 3, 2021 | 1,666.00 |